Today: 28 April 2026

Jerzy Lewandowski

Grok 4: Inside Elon Musk’s Most Powerful (and Controversial) AI Chatbot Yet

The Race to $-Per-Token: Coding Models Get Fast & Frugal

xAI launched Grok Code Fast 1 in August 2025, offering 256k context and low pricing at $0.20 per million input tokens. Meta’s Code Llama remains free and open-source, with its 70B model rivaling proprietary benchmarks and no token fees. GitHub Copilot charges $10–$39 monthly, integrating multiple AI models for code completion. Code Llama can run locally, while Grok and Copilot require cloud access.
14 September 2025
·
AI Voice Clones Are Taking Over – Inside the Synthetic Voice Revolution of 2025

SoundHound AI: The Voice Tech Disruptor Challenging Siri, Alexa, and Wall Street Expectations

SoundHound AI reported Q2 2025 revenue of $42.7 million, up 217% year-over-year, and raised its full-year sales outlook to up to $178 million. The company licenses voice AI tech to major automakers and restaurant chains, with a bookings backlog exceeding $1 billion. Wall Street analysts rate the stock mostly “Moderate Buy,” citing growth potential and competition. SoundHound claims its Polaris speech model outperforms rivals in accuracy.
14 September 2025
·

Stock Market Today

  • Amneal Pharmaceuticals (AMRX) Valuation at 1.69x Sales Highlights Investor Interest
    April 28, 2026, 2:07 PM EDT. Amneal Pharmaceuticals (AMRX) has outperformed its sector with a 62.2% rise over 12 months against a 3.1% gain in its Zacks sub-industry. Despite a slight 0.2% dip year-to-date, the stock remains attractive at a valuation of 1.69 times sales. Amneal's strategic shift toward higher-margin Specialty products and disciplined operations boosted its adjusted gross margin by 50 basis points to 43% in 2025. The company expects steady 2026 revenues between $3.05 billion and $3.15 billion, with improved profitability reflected in adjusted EBITDA guidance of $740 million to $770 million and EPS of 95 cents to $1.05. Cash flow and leverage trends also improved, supporting a balanced financial outlook amid generics pricing pressure.

Latest article

Aterian Stock Soars as $18 Million Brand Sale and David Lazar Investment Reset the Company

Aterian Stock Soars as $18 Million Brand Sale and David Lazar Investment Reset the Company

28 April 2026
Aterian Inc. agreed to sell its main e-commerce brands to Trademark Global for $18 million in cash and secured a separate $7 million investment from David Lazar. Shares surged 89% to $1.24, with trading volume over 189 million. The asset sale, pending stockholder approval, includes brands like Squatty Potty and hOmeLabs. Lazar is set to become CEO after the second investment tranche closes.
Vertiv Stock Slides as Strategic Thermal Labs Deal Sharpens AI Cooling Push

Vertiv Stock Slides as Strategic Thermal Labs Deal Sharpens AI Cooling Push

28 April 2026
Vertiv Holdings closed its acquisition of Strategic Thermal Labs, expanding its AI data-center cooling capabilities, the company said Monday. The deal follows a 30% jump in Vertiv’s first-quarter net sales to $2.65 billion and an upgraded 2026 outlook. Terms were not disclosed. Vertiv shares traded lower midday in New York, recently at $300.58.
Cosan’s Compass IPO Could Crack Open Brazil’s Listing Market With R$5.1 Billion Sale

Cosan’s Compass IPO Could Crack Open Brazil’s Listing Market With R$5.1 Billion Sale

28 April 2026
Cosan SA moved to take Compass Gás e Energia public in an all-secondary share sale, aiming to raise up to 5.1 billion reais. The base offer covers about 89.3 million shares at 28 to 35 reais each, with Cosan planning to use proceeds to cut debt. Compass filed to join B3’s Novo Mercado and completed a restructuring to enable the deal. The IPO would be Brazil’s largest since 2021.
Go toTop